대한장애인치과학회지 (The Journal of Korea Assosiation for Disability and Oral Health)

  • 제9권1호
  • /
  • Pages.46-50
  • /
  • 2013
  • /
  • 1738-8813(pISSN)
  • /
  • 2287-7142(eISSN)
대한장애인치과학회 (Korean Association for Disability and Oral Health)
권호 표지
DOI QR코드

DOI QR Code

미다졸람 경구 전투약을 이용한 발달장애 환아의 전신마취하 우식치료 증례보고

CARIES TREATMENT OF A MIDAZOLAM-PREMEDICATED PATIENT WITH DEVELOPMENTAL DISORDERS : A CASE REPORT

  • 김효은 (서울대학교 치의학대학원 소아치과학교실) ;
  • 신터전 (서울대학교 치의학대학원 소아치과학교실) ;
  • 김영재 (서울대학교 치의학대학원 소아치과학교실) ;
  • 김정욱 (서울대학교 치의학대학원 소아치과학교실) ;
  • 장기택 (서울대학교 치의학대학원 소아치과학교실) ;
  • 이상훈 (서울대학교 치의학대학원 소아치과학교실) ;
  • 김종철 (서울대학교 치의학대학원 소아치과학교실) ;
  • 현홍근 (서울대학교 치의학대학원 소아치과학교실)
  • Kim, Hyo-Eun (Department of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Shin, Teo-Jeon (Department of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Kim, Young-Jae (Department of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Kim, Jung-Wook (Department of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Jang, Ki-Taeg (Department of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Lee, Sang-Hoon (Department of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Kim, Chong-Chul (Department of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Hyun, Hong-Keun (Department of Pediatric Dentistry, School of Dentistry, Seoul National University)
  • 투고 : 2013.06.11
  • 심사 : 2013.06.12
  • 발행 : 2013.06.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

저자는 본 증례를 통하여 발달장애 환자의 치과치료 시 다음과 같은 지견을 얻었다. 1. 발달장애 환자의 경우 불량한 구강위생 등으로 인하여 치과적 치료가 필요한 경우가 많다. 2. 발달장애 환자의 경우 비약물적 행동조절만으로 치과적 치료를 위한 충분한 협조도를 얻기가 어렵다. 3. 발달장애 환자에 있어서 midazolam 구강 전투약을 이용한 전신마취 하 치과치료가 매우 유용하게 적용될 수 있다. 4. 숙련된 의료진의 철저한 감시하에 정맥주사용 midazolam 제재를 설탕시럽에 혼합하여 투약한다면 전투약을 통해 기대하는 효과를 얻을 수 있다.

Developmental disorders are a group of psychiatric conditions originating in childhood that involve serious impairments in different areas. These disorders comprise language disorders, learning disorders, motor disorders and autism spectrum disorders. Midazolam is a short-acting drug in the benzodiazepine class developed by Hoffmann-La Roche in the 1970s. The drug is used for treatment of acute seizures, moderate to severe insomnia, and for inducing sedation and amnesia before medical procedures. It possesses profoundly potent anxiolytic, amnestic, hypnotic, anticonvulsant, skeletal muscle relaxant, and sedative properties. The anterograde amnesia property of midazolam is useful for premedication before surgery to inhibit unpleasant memories. This article presents a case report including caries treatment of a 8-year-old male patient with developmental disorders using oral midazolam premedication as an alternative method of behavior management prior to general anesthesia.

키워드

참고문헌

  1. Rutter M, Bishop DVM, Pine DS, Scott S, Stevenson J, Taylor E, Thapar A : Rutter's Child and Adolescent Psychiatry, 5th Edition. Blackwell Publishing Ltd. pp. 32-33, 2009.
  2. Thikkurissy S, Lal S: Oral health burden in children with systemic diseases. Dent Clin North Am, 53(2):351-357, 2009. https://doi.org/10.1016/j.cden.2008.12.004
  3. Mandrioli R, Mercolini L, Raggi MA: Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab, 9(8):827-844, 2008. https://doi.org/10.2174/138920008786049258
  4. Olkkola, KT.; Ahonen J: Midazolam and other benzodiazepines. Handb Exp Pharmacol, (182): 335-60, 2008.
  5. Barash PG, Cullen BF, Stoelting RK, Cahalan M, Stock MC: Clinical Anesthesia, 6th Edition. Lippincott Williams Wilkins. p. 588, 2009.
  6. Khail SN, Vije HN, Kee SS, Farag A, Hanna E, Chuang AZ: A paediatric trial comparing midazolam/Syrpalta mixture with premixed midazolam syrup (Roche). Paediatr Anaesth, 13(3):205-209, 2003. https://doi.org/10.1046/j.1460-9592.2003.01062.x
  7. Shrestha S, Shrestha BR: Oral administration of intravenous solution of midazolam mixed in syrup of paracetamol is an effective way of premedicating children undergoing surgery under general anaesthesia. Kathmandu Univ Med J, 5(4):449-455, 2007.
  8. Yuen VM, Hui TW, Irwin MG, Yuen MK: A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg, 106(6):1715-1721, 2008. https://doi.org/10.1213/ane.0b013e31816c8929
  9. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL: Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. Clin Psychopharmacol, 10(4):244-251, 1990.
  10. Jackson K, Winkley R, Faust OA, Cermak EG, Burtt MM: Behavior changes indicating emotional trauma in tonsillectomized children. Pediatrics, 12(1):23-27, 1953.
  11. Eckenhoff JE: Relationship of anesthesia to postoperative personality changes in children. AMA Am J Dis Child, 86(5):587-591, 1953.
  12. Vernon DT, Schulman JL, Foley JM: Changes in children's behavior after hospitalization. Am J Dis Child, 111(6):581-593, 1966. https://doi.org/10.1001/archpedi.1966.02090090053003
  13. Brzustowicz RM, Nelson DA, Betts EK, Rosenberry KR, Swedlow DB: Efficacy of oral premedication for pediatric outpatient surgery. Anesthesiology, 60(5):475-477, 1984. https://doi.org/10.1097/00000542-198405000-00014
  14. Dundee JW, Halliday NJ, Harper KW, Brogden RN: Midazolam. A review of its pharmacological properties and therapeutic use. Drugs, 28(6):519-543, 1984. https://doi.org/10.2165/00003495-198428060-00002
  15. Feld LH, Negus JB, White PF: Oral midazolam preanesthetic medication in pediatric outpatients. Anesthesiology, 73(5):831-834, 1990. https://doi.org/10.1097/00000542-199011000-00006
  16. Walker SE, Grad HA, Haas DA, Mayer A: Stability of parenteral midazolam in an oral formulation. Anesth Prog, 44(1):17-22, 1997.